Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paige Lewis

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|October 25, 2017
Reports of Postural Orthostatic Tachycardia Syndrome After Human Papillomavirus Vaccination in the Vaccine Adverse Event Reporting SystemJorge Arana, Adamma Mba-Jonas, Christopher Jankosky, et al.
Pharmacoepidemiology and Drug Safety|March 13, 2012
The risk of Guillain-Barré syndrome associated with influenza A (H1N1) 2009 monovalent vaccine and 2009-2010 seasonal influenza vaccines: results from self-controlled analysesJerome I Tokars, Paige Lewis, Frank DeStefano, et al.
Vaccine|September 27, 2014
Post-licensure surveillance of trivalent live attenuated influenza vaccine in adults, United States, Vaccine Adverse Event Reporting System (VAERS), July 2005-June 2013Penina Haber, Pedro L Moro, Michael M McNeil, et al.
The Lancet. Infectious Diseases|August 21, 2015
Preparation for global introduction of inactivated poliovirus vaccine: safety evidence from the US Vaccine Adverse Event Reporting System, 2000-12Shahed Iqbal, Jing Shi, Katherine Seib, et al.
Human Vaccines & Immunotherapeutics|March 28, 2018
Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2015Elaine R Miller, Paige Lewis, Tom T Shimabukuro, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 24, 2012
Postlicensure safety surveillance for high-dose trivalent inactivated influenza vaccine in the Vaccine Adverse Event Reporting System, 1 July 2010-31 December 2010Pedro L Moro, Jorge Arana, Maria Cano, et al.
British Journal of Clinical Pharmacology|September 20, 2018
Safety of bivalent human papillomavirus vaccine in the US vaccine adverse event reporting system (VAERS), 2009-2017Tiffany A Suragh, Paige Lewis, Jorge Arana, et al.
JAMA Pediatrics|January 8, 2014
Risk of fever after pediatric trivalent inactivated influenza vaccine and 13-valent pneumococcal conjugate vaccineMelissa S Stockwell, Karen Broder, Philip LaRussa, et al.
Journal of the Pediatric Infectious Diseases Society|June 16, 2016
Assessing Fever Frequency After Pediatric Live Attenuated Versus Inactivated Influenza VaccinationMelissa S Stockwell, Karen R Broder, Paige Lewis, et al.
Pediatrics|May 15, 2013
Intussusception after rotavirus vaccines reported to US VAERS, 2006-2012Penina Haber, Manish Patel, Yi Pan, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|October 25, 2017
Reports of Postural Orthostatic Tachycardia Syndrome After Human Papillomavirus Vaccination in the Vaccine Adverse Event Reporting SystemJorge Arana, Adamma Mba-Jonas, Christopher Jankosky, et al.
Pharmacoepidemiology and Drug Safety|March 13, 2012
The risk of Guillain-Barré syndrome associated with influenza A (H1N1) 2009 monovalent vaccine and 2009-2010 seasonal influenza vaccines: results from self-controlled analysesJerome I Tokars, Paige Lewis, Frank DeStefano, et al.
Vaccine|September 27, 2014
Post-licensure surveillance of trivalent live attenuated influenza vaccine in adults, United States, Vaccine Adverse Event Reporting System (VAERS), July 2005-June 2013Penina Haber, Pedro L Moro, Michael M McNeil, et al.
The Lancet. Infectious Diseases|August 21, 2015
Preparation for global introduction of inactivated poliovirus vaccine: safety evidence from the US Vaccine Adverse Event Reporting System, 2000-12Shahed Iqbal, Jing Shi, Katherine Seib, et al.
Human Vaccines & Immunotherapeutics|March 28, 2018
Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2015Elaine R Miller, Paige Lewis, Tom T Shimabukuro, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 24, 2012
Postlicensure safety surveillance for high-dose trivalent inactivated influenza vaccine in the Vaccine Adverse Event Reporting System, 1 July 2010-31 December 2010Pedro L Moro, Jorge Arana, Maria Cano, et al.
British Journal of Clinical Pharmacology|September 20, 2018
Safety of bivalent human papillomavirus vaccine in the US vaccine adverse event reporting system (VAERS), 2009-2017Tiffany A Suragh, Paige Lewis, Jorge Arana, et al.
JAMA Pediatrics|January 8, 2014
Risk of fever after pediatric trivalent inactivated influenza vaccine and 13-valent pneumococcal conjugate vaccineMelissa S Stockwell, Karen Broder, Philip LaRussa, et al.
Journal of the Pediatric Infectious Diseases Society|June 16, 2016
Assessing Fever Frequency After Pediatric Live Attenuated Versus Inactivated Influenza VaccinationMelissa S Stockwell, Karen R Broder, Paige Lewis, et al.
Pediatrics|May 15, 2013
Intussusception after rotavirus vaccines reported to US VAERS, 2006-2012Penina Haber, Manish Patel, Yi Pan, et al.
Pageof 6